Publications by authors named "Sudhir Venkatesan"

Claim this Profile
D
Dimensionality Reduction Techniques for Improving Propensity Score Specification: An Application to a Cohort Study Using Claims Data.
Sudhir Venkatesan, Jonatan Nåtman, Eva Lesén, Stefan Franzén, Sima Shahsavari

Pharmacoepidemiol Drug Saf· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Healthcare Resource Utilization and Disease Outcomes in Adults Hospitalized with Human Metapneumovirus and Respiratory Syncytial Virus.
Emily Rayens, Lina S Sy, Lei Qian, Bradley K Ackerson, Jaejin An, Sudhir Venkatesan

J Infect Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correcting for the Inflated Adult Population Denominator in an English Nationwide Health Care Cohort: Database Analysis Study.
Sudhir Venkatesan, Mark Joy, Gavin Jamie, Debasish Kar, Robert Williams

JMIR Public Health Surveill· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Features influencing the health and economic impact of preventing COVID-19 in immunocompromised individuals.
Siyu Chen, Sudhir Venkatesan, Sofie Arnetorp, Klas Bergenheim, Sabada Dube

PLoS Comput Biol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of AZD7442 (Tixagevimab/Cilgavimab) for Pre-Exposure Prophylaxis Against COVID-19 Hospitalization in Israel During the Omicron Sub-Variant Time Period.
Samah Hayek, Joseph Levy, Galit Shaham, Noa Dagan, Danielle Serby, Sudhir Venkatesan

Infect Dis Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to 'Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study' [The Lancet Regional Health - Europe 35 (2023) 100747].
Rachael A Evans, Sabada Dube, Yi Lu, Mark Yates, Sofie Arnetorp, Sudhir Venkatesan

Lancet Reg Health Eur· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Association Between Physical Distancing Behaviors to Avoid COVID-19 and Health-Related Quality of Life in Immunocompromised and Nonimmunocompromised Individuals: Patient-Informed Protocol for the Observational, Cross-Sectional EAGLE Study.
Paul Williams, Timothy A Herring, Renata T C Yokota, Tiago Maia, Sudhir Venkatesan

JMIR Res Protoc· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Creating a Modified Version of the Cambridge Multimorbidity Score to Predict Mortality in People Older Than 16 Years: Model Development and Validation.
Debasish Kar, Kathryn S Taylor, Mark Joy, Sudhir Venkatesan, Wilhelmine Meeraus

J Med Internet Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperkalaemia-related reduction of RAASi treatment associates with more subsequent inpatient care.
Maria K Svensson, Toyoaki Murohara, Eva Lesén, Matthew Arnold, Thomas Cars, Sudhir Venkatesan

Nephrol Dial Transplant· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of AZD7442 (Tixagevimab/Cilgavimab) COVID-19 Pre-exposure Prophylaxis (PrEP) in the Largest Health Maintenance Organization in Israel: Real-world Uptake and Sociodemographic and Clinical Characteristics Across Immunocompromised Patient Groups.
Samah Hayek, Joseph Levy, Galit Shaham, Noa Dagan, Danielle Serby, Sudhir Venkatesan

Infect Dis Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AZD1222 effectiveness against severe COVID-19 in individuals with comorbidity or frailty: The RAVEN cohort study.
Wilhelmine Meeraus, Mark Joy, Mario Ouwens, Kathryn S Taylor, Sudhir Venkatesan

J Infect· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study.
Rachael A Evans, Sabada Dube, Yi Lu, Mark Yates, Sofie Arnetorp, Sudhir Venkatesan

Lancet Reg Health Eur· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns and outcomes for patients with malignant pleural mesothelioma in England in 2013-2017: A nationwide CAS registry analysis from the I-O Optimise initiative.
Paul Baas, Melinda J Daumont, Laure Lacoin, John R Penrod, Robert Carroll, Sudhir Venkatesan

Lung Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient characteristics associated with COVID-19 positivity and fatality in Nigeria: retrospective cohort study.
Kelly Osezele Elimian, Chinwe Lucia Ochu, Blessing Ebhodaghe, Puja Myles, Emily E Crawford, Sudhir Venkatesan

BMJ Open· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel framework for evaluating the impact of individual decision-making on public health outcomes and its potential application to study antiviral treatment collection during an influenza pandemic.
Sudhir Venkatesan, Jonathan S Nguyen-Van-Tam, Peer-Olaf Siebers

PLoS One· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection.
Sudhir Venkatesan, Puja R Myles, Kirsty J Bolton, Stella G Muthuri, Tarig Al Khuwaitir

J Infect Dis· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative chronic beta-blocker prescription in elderly patients as a risk factor for postoperative mortality stratified by preoperative blood pressure: a cohort study.
Sudhir Venkatesan, Mads Emil Jørgensen, Helen J Manning, Charlotte Andersson, Abdul M Mozid

Br J Anaesth· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiviral treatment for outpatient use during an influenza pandemic: a decision tree model of outcomes averted and cost-effectiveness.
Sudhir Venkatesan, Cristina Carias, Matthew Biggerstaff, Angela P Campbell, Jonathan S Nguyen-Van-Tam

J Public Health (Oxf)· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Jones et al.
Sudhir Venkatesan, Puja R Myles, Ziad Memish, Jonathan S Nguyen-Van-Tam

Clin Infect Dis· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Outpatient Neuraminidase Inhibitor Treatment in Patients Infected With Influenza A(H1N1)pdm09 at High Risk of Hospitalization: An Individual Participant Data Metaanalysis.
Sudhir Venkatesan, Puja R Myles, Jo Leonardi-Bee, Stella G Muthuri, Malak Al Masri

Clin Infect Dis· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: association of preoperative cardiovascular drugs with short-term mortality after coronary artery bypass grafting.
Robert D Sanders, Sudhir Venkatesan, George N Okoli, Puja Myles

Eur J Anaesthesiol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence synthesis and decision modelling to support complex decisions: stockpiling neuraminidase inhibitors for pandemic influenza usage.
Samuel I Watson, Yen-Fu Chen, Jonathan S Nguyen-Van-Tam, Puja R Myles, Sudhir Venkatesan

F1000Res· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: an individual participant data meta-analysis.
Stella G Muthuri, Sudhir Venkatesan, Puja R Myles, Jo Leonardi-Bee, Wei Shen Lim

Influenza Other Respir Viruses· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A UK general practice population cohort study investigating the association between lipid lowering drugs and 30-day mortality following medically attended acute respiratory illness.
Roshni Joshi, Sudhir Venkatesan, Puja R Myles

PeerJ· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of five preoperative cardiovascular drugs on mortality after coronary artery bypass surgery: A retrospective analysis of an observational study of 16, 192 patients.
Sudhir Venkatesan, George N Okoli, Abdul M Mozid, Thomas W H Pickworth, Michael P W Grocott

Eur J Anaesthesiol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis